M, T., D, B., R, K., T, M., K, N., V, S., . . . KA, M. (2017). Discovery and evaluation of 1H-pyrrolo[2,3-b]pyridine based selective and reversible small molecule BTK inhibitors for the treatment of rheumatoid arthritis. Bioorganic & medicinal chemistry letters, 27(8), 1867. https://doi.org/10.1016/j.bmcl.2017.02.026
Chicago Style (17th ed.) CitationM, Thakkar, et al. "Discovery and Evaluation of 1H-pyrrolo[2,3-b]pyridine Based Selective and Reversible Small Molecule BTK Inhibitors for the Treatment of Rheumatoid Arthritis." Bioorganic & Medicinal Chemistry Letters 27, no. 8 (2017): 1867. https://doi.org/10.1016/j.bmcl.2017.02.026.
MLA (9th ed.) CitationM, Thakkar, et al. "Discovery and Evaluation of 1H-pyrrolo[2,3-b]pyridine Based Selective and Reversible Small Molecule BTK Inhibitors for the Treatment of Rheumatoid Arthritis." Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 8, 2017, p. 1867, https://doi.org/10.1016/j.bmcl.2017.02.026.